Roos J. Blankespoor
Papers
1
Total Citations
76
H-Index
1
About
Dr. Roos J. Blankespoor is a pioneering clinical researcher whose work bridges the critical gap between neuroimmunology and developmental psychiatry. Her most influential study, "Late onset autism and anti-NMDA-receptor encephalitis" (2011), with 76 citations, fundamentally challenged conventional views of autism spectrum disorders by demonstrating that some cases of regressive autism may be triggered by an autoimmune encephalitis. This landmark paper established a new diagnostic paradigm, showing that anti-NMDA-receptor antibodies can cause a reversible, treatable form of autism-like symptoms in children and adolescents. Dr. Blankespoor's research has been instrumental in alerting clinicians to consider autoimmune etiologies in patients presenting with late-onset or regressive autism, leading to earlier diagnosis and potentially life-changing immunotherapy interventions. Her work has significantly advanced the understanding of how neuroinflammatory processes can mimic or exacerbate neurodevelopmental conditions, opening new avenues for targeted treatments. Through her meticulous case studies and clinical insights, Dr. Blankespoor has become a leading voice in the emerging field of autoimmune neuropsychiatry, inspiring a generation of researchers to explore the immune system's role in complex developmental disorders.
Research Focus
Key Achievements
Top Papers
- 1Late onset autism and anti-NMDA-receptor encephalitis76 citations · 2011